a few people working at a table

Press Releases

Ladenburg Acts as Exclusive Placement Agent in $3 Million Private Placement for NovaBay Pharmaceuticals, Inc.

Transaction Information NovaBay Pharmaceuticals, Inc. (NYSE American: NBY) announced it entered into a securities...

Ladenburg Acts as Sole Book-Running Manager in $2.55 Million Offering for Intelligent Bio Solutions Inc.

Transaction Information Intelligent Bio Solutions Inc. (Nasdaq: INBS) (the "Company") announced the closing of...

Ladenburg Acts as Exclusive Placement Agent in $8 Million Offering for Ra Medical Systems, Inc.

Transaction Information Ra Medical Systems, Inc. (NYSEAmerican: RMED) announced that it has closed its...

Ladenburg Acts as Exclusive Placement Agent in $6 Million Offering for Midatech Pharma PLC

Transaction Information Midatech Pharma PLC (AIM:MTPH.L)(Nasdaq:MTP) announced that it has raised $6.0 million...

Ladenburg Thalmann Acts as Financial Advisor to Board of Trustees of Vertical Capital Income Fund in New Investment Advisory Agreement with Carlyle

Transaction Information Ladenburg Thalmann & Co. Inc. served as financial advisor to Board of Trustees of...

Ladenburg Serves Exclusive Roles in Completion of Ra Medical Systems Merger with Catheter Precision and $9.3 Million Financing

Ladenburg acted as the Financial Advisor in the Merger and Exclusive Warrant Inducement Agent and Placement Agent in...

Ladenburg Acts as Exclusive Placement Agent in $10 Million Financing for Midatech Pharma and Exclusive Advisor in Merger Between Bioasis Technologies and Midatech

Transaction Information Merger Bioasis Technologies Inc. (TSX.V:BTI), a multi-asset rare and orphan...

Ladenburg Thalmann Acts as Sole Book-Running Manager and Exclusive Placement Agent for $32 Million Offering for NeuroBo Pharmaceuticals, Inc.

Transaction Information NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO) announced the closing of an underwritten...

Ladenburg Acts as Exclusive Warrant Solicitation Agent in $3.12 Million Offering for Kiora Pharmaceuticals, Inc.

Transaction Information Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) announced it has entered into warrant...

  • 1
  • ...
  • 6
  • ...
  • 36